Acyclovir; Hydrocortisone Patent Expiration
Acyclovir; Hydrocortisone is used for early treatment of recurrent herpes labialis (cold sores) in adults and adolescents to reduce likelihood of ulcerative cold sores and shorten lesion healing time. It was first introduced by Bausch Health Us Llc
Acyclovir; Hydrocortisone Patents
Given below is the list of patents protecting Acyclovir; Hydrocortisone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xerese | US7223387 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
Feb 28, 2021
(Expired) | Bausch |
| Xerese | US6514980 | Nucleoside analogs in combination therapy of herpes simplex infections |
Jan 24, 2017
(Expired) | Bausch |
| Xerese | USRE39264 | Pharmaceutical combination |
Feb 02, 2016
(Expired) | Bausch |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Acyclovir; Hydrocortisone's patents.
Latest Legal Activities on Acyclovir; Hydrocortisone's Patents
Given below is the list recent legal activities going on the following patents of Acyclovir; Hydrocortisone.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 02 Nov, 2018 | US7223387 |
| Correspondence Address Change Critical | 23 Feb, 2012 | US7223387 |
| Change in Power of Attorney (May Include Associate POA) Critical | 23 Feb, 2012 | US7223387 |
| Patent Issue Date Used in PTA Calculation Critical | 29 May, 2007 | US7223387 |
| Recordation of Patent Grant Mailed Critical | 29 May, 2007 | US7223387 |
| Electronic Review Critical | 12 May, 2007 | US7223387 |
| Issue Notification Mailed Critical | 11 May, 2007 | US7223387 |
| Email Notification Critical | 11 May, 2007 | US7223387 |
| Dispatch to FDC | 25 Apr, 2007 | US7223387 |
| Application Is Considered Ready for Issue Critical | 25 Apr, 2007 | US7223387 |
Acyclovir; Hydrocortisone's Family Patents
